BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22689119)

  • 1. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
    Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
    Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
    Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
    Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
    Gomez Vazquez M; Navarra Amayuelas R
    Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
    Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
    Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
    Wang L; Gao T; Wang G
    J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
    Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
    Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.
    Fujimoto N; Kito K; Yoshida T; Tanaka T
    Acta Derm Venereol; 2015 Jan; 95(1):106-7. PubMed ID: 24890876
    [No Abstract]   [Full Text] [Related]  

  • 9. Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
    Hosler GA; Liégeois N; Anhalt GJ; Moresi JM
    J Cutan Pathol; 2008 Nov; 35(11):1063-7. PubMed ID: 18544066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
    Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
    Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
    Lin KW; Lee YS; Phipps C
    Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis.
    Terui H; Yamasaki K; Yoshida S; Aiba S
    Acta Derm Venereol; 2018 Jan; 98(1):128-129. PubMed ID: 28597026
    [No Abstract]   [Full Text] [Related]  

  • 15. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
    Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
    Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma.
    Cardoso J; Duhra P; Thway Y; Calonje E
    Am J Dermatopathol; 2012 Oct; 34(7):762-5. PubMed ID: 22688398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules.
    Ito Y; Goto M; Hatano Y; Kawamoto M; Ohishi M; Takayasu S; Katagiri K; Fujiwara S
    Clin Exp Dermatol; 2012 Mar; 37(2):128-31. PubMed ID: 21883402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis.
    Laetsch B; Hofbauer G; Kempf W; Burg G; Dummer R
    Dermatology; 2005; 210(4):341-5. PubMed ID: 15942225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
    Marzano AV; Ghislanzoni M; Gianelli U; Caputo R; Alessi E; Berti E
    Dermatology; 2005; 211(3):281-5. PubMed ID: 16205076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.